Patents by Inventor Kelli VanDussen

Kelli VanDussen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11867701
    Abstract: The present disclosure provides methods for classifying a cell as abnormal based on HD5 protein detection as well as methods for predicting prognosis of a subject with Crohn's disease based on HD5 protein detection.
    Type: Grant
    Filed: April 27, 2017
    Date of Patent: January 9, 2024
    Assignee: Washington University
    Inventors: Thaddeus Stappenbeck, Ta-Chiang Liu, Kelli VanDussen
  • Publication number: 20220082548
    Abstract: The present disclosure provides methods of selecting a treatment for an inflammatory bowel disease in a subject. In particular, using an indicator of epithelial absorption and metabolism the present disclosure provides method for determining the likelihood a subject is responsive or non-responsive to an inflammatory bowel disease therapeutic agent. The method includes providing a baseline measurement of a microvillus length in the small intestine of a subject, selecting a treatment for the subject according to a treatment criteria, and administering the treatment to the subject.
    Type: Application
    Filed: September 13, 2021
    Publication date: March 17, 2022
    Applicant: Washington University
    Inventors: Thaddeus Stappenbeck, Kelli VanDussen
  • Publication number: 20210223265
    Abstract: The present disclosure provides methods for classifying a cell as abnormal based on HD5 protein detection as well as methods for predicting prognosis of a subject with Crohn's disease based on HD5 protein detection.
    Type: Application
    Filed: April 27, 2017
    Publication date: July 22, 2021
    Applicant: Washington University
    Inventors: Thaddeus Stappenbeck, Ta-Chiang Liu, Kelli VanDussen